Kimberly R. Peery Net Worth

Ms. Kimberly R. Peery biography

Kimberly R. Peery is the Chief Financial Officer at Stereotaxis.

What is the salary of Ms Peery?

As the Chief Financial Officer of Stereotaxis, the total compensation of Ms Peery at Stereotaxis is $229,357. There are 7 executives at Stereotaxis getting paid more, with David Fischel having the highest compensation of $240,300.

What's Ms Peery's mailing address?

Kimberly's mailing address filed with the SEC is C/O STEREOTAXIS, INC., 710 NORTH TUCKER BLVD.; SUITE 110, ST. LOUIS, MO, 63101.

Insiders trading at Stereotaxis

Over the last 6 years, insiders at Stereotaxis have traded over $16,447,723 worth of Stereotaxis stock and bought 502,585 units worth $872,120 . The most active insiders traders include Joe E Kiani, Paul J Isaac, and Myriam Curet. On average, Stereotaxis executives and independent directors trade stock every 39 days with the average trade being worth of $124,591. The most recent stock trade was executed by Paul J Isaac on 28 May 2024, trading 1,254 units of STXS stock currently worth $2,358.

What does Stereotaxis do?

Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (RMN) systems for use in hospital's interventional surgical suite to improve the treatment of arrhythmias and coronary artery disease in the United States and internationally. Its RMN systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is based in St. Louis, Missouri.

Stereotaxis executives and stock owners

Stereotaxis executives and other stock owners filed with the SEC include:

• Ross Levin,
  Independent Director
• Robert Messey,
  Independent Director
• Arun Menawat,
  Independent Director
• Joseph Kiani,
  Independent Director
• David Benfer,
  Lead Independent Director
• Nathan Fischel,
  Director
• David Fischel,
  Chairman of the Board, Chief Executive Officer
• Kimberly R. Peery,
  Chief Financial Officer
• Kimberly Peery,
  Chief Financial Officer
• Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., CFA, CPA,
  CEO & Chairman
• David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., CFA, CPA,
  CEO & Chairman
• Guy Judkowski,
  Equity Portfolio Mang.
• Joe E Kiani,
  Director
• Paul J Isaac,
  Director
• Kevin M. Barry,
  Chief Legal Officer & Secretar
• Martin C Stammer,
  Chief Financial Officer
• Myriam Curet,
  Director